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The fetal circulation contains several embryo-specific proteins normally present in the
serum of adult individuals in very small concentrations . Pedersen (1) described the first
protein of this group in calf serum (fetuin) and since then several embryo-specific serum
proteins have been demonstrated in a number of mammalian species (2, 3) . Alpha-feto-
protein(AFP),' an embryo-specific protein synthesized by the liver, is the first alpha-
protein to appear in mammalian sera during ontogenetic development and is the
dominant serum protein in early embryonic life at a time when albumin and transferrin
are present in trace amounts (4, 5) . The physiological level of AFP in the fetus reaches
milligram amounts (4 mg/ml in human) during early-mid gestation and then drops
linearly as birth approaches and shortly thereafter falls to normal background adult levels
which are on the order of 0.001% of the maximal fetal levels . It has been suggested that the
appearance of AFP is due to the absence of a repressor which normally appears toward the
end of embryonic life (6) . This protein has been considered a tumor-associated embryonic
antigen since Abelev and co-workers (7) originally observed the reappearance of high
concentrations of AFP in the serum of patients with primary liver cancer . Elevated AFP
levels have subsequently been shown to occur in other malignant (especially teratocar-
cinomas) as well as nonmalignant conditions, particularly those associated with liver
regeneration (8) . However, the relative specificity of markedly elevated AFP levels for
primary liver cancer has been emphasized (9) .
The function of AFP in the fetus is unknown, nor is it known why there is a
re-expression of the protein in certain pathological conditions during postnatal life . One
intriguing possibility is that AFP has immunoregulatory properties which are important
for the exemption of the histoincompatible embryo from immunological attack by the
maternal immune system . Furthermore, the demonstration of immunosuppressive
activity by AFP in relation to its occurrence in certain malignant conditions would be
consistent with the association known to exist between various forms of immune
deficiency and neoplastic disease .
* This investigation was supported in part by U . S . Public Health Research Grant RO 1 AM 17554
from the National Institute ofArthritis and Metabolic Diseases, and the American Cancer Society .
`Abbreviations used in this paper : AFP, alpha-fetoprotein ; MAF, mouse amniotic fluid ; NMS,
normal mouse serum ; PBS, phosphate-buffered saline ; PFC, plaque-forming cells ; WMS, whole
mouse serum .
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During the course of a previous study (10) we found that mouse amniotic fluid
administered in vivo significantly suppresses antibody formation. Since one of
the major unique proteins in amniotic fluid is AFP, the present study was
initiated to investigate the effect of AFPboth as it occurs in amniotic fluid and in
the isolated form on the primary and secondary antibody response in vitro. A
subsequent paper will describe the effects of AFP on mixed lymphocyte reactivity
and mitogen-induced lymphocyte transformation .'
Materials and Methods
Animals.
￿
CBA/J and BALB/c mice, purchased from Jackson Laboratories, Bar Harbor, Maine,
were used in all experiments. Pregnant HAACR mice, bred locally at the Mayo Clinic, were used as a
source of amniotic fluid.
Amniotic Fluid Collection. Mouse amniotic fluid (MAF) was collected from Swiss or HAACR
mice in the late second and early third trimester of pregnancy. Pregnant animals were sacrificed by
cervical dislocation and the embryonic sacs were exposed by dissecting away the placenta. The fluid
was collected by puncturing the individual sacs with a 20 gauge needle and a 1 ml syringe. Special
care was taken not to contaminate the MAF with blood . Approximately 1 ml of fluid was collected
from each pregnant mouse. The fluids were pooled, centrifuged, and stored frozen for further use.
The total protein concentration of MAFwas determined as the dry weight of a lyophilized aliquot
of the fluid following exhaustive dialysis against water. The extinction coefficients of the isolated
protein components of MAF were determined by lyophilizing 1-ml aliquots of the purified proteins
after exhaustive dialysis against 0.1 M NH,HCO, buffer. The dry material was weighed on an
analytical balance, redissolved in a calibrated tube to 1 ml with phosphate-buffered saline (PBS), pH
7.2, andextinctions at 280mfe determined in a Hitachi Perkin-Elmer, model 139 spectrophotometer.
Antisera. Antiserum to MAF was prepared in rabbits by subcutaneous injection of MAF
supplemented with Freund's complete adjuvant. The injections, totaling 1 ml each, were given 2 wk
apart . Serum obtained at various times after the second series of injections was used for the
subsequent immunochemical characterization andpurification of amniotic fluid protein components.
The antiserum was rendered specific for AFP by absorption with lyophilized normal mouse serum
(NMS). Rabbit antimouse transferrin and albumin were prepared by a similar immunization
regimen using purified mouse serum, transferrin, and albumin . Monospecific antisera to mouse
immunoglobulins were prepared in rabbits and goats as described in detail elsewhere (11) . Antisera
were prepared against the papain Fc fragment of MOPC-31C (-rG,), Adj-PC5 ('YG,,), and MOPC-195
(yG,b) myeloma protein isolated from serum as previously described (12). Antimouse -yG, was made
in rabbits with J-606 (kindly supplied by Dr. Howard Grey, National Jewish Hospital, Denver, Colo.)
with a mixture of purified MOPC-31C, Adj-PC5, and MOPC-195 myeloma proteins. Rabbit
anti-MPC-1 myeloma yA antisera were similarly prepared and absorbed with newborn mouse serum.
Multiple controls for the monospecificity of each antisera were done, including immunofluorescent
staining of myeloma tumors representative of the major immunoglobulin classes.
Affinity Chromatography .
￿
Antibody-agarose affinity chromatography was performed according
to Cuatrecasas (13) by covalently linking at alkaline pH (10, footnote 2) the gammaglobulin fractions
of the rabbit antisera to cyanogen-bromide-activated Sepharose 4B (CNBr-Sepharose from Phar-
macia Fine Chemicals, Piscataway, N.J.). The -y-globulin fraction was obtained by sequential
precipitation with 18%, 12%, and a second 12% Na,SO,. Approximately 1 x 20-cm columns were
equilibrated in 0.5 M NaCl in PBS. Proteins not retained by the antibody-coated gel passed through
the column in the buffer and were termed the fall-through preparations. The proteins bound by the
gel were eluted with either 0.2 M glycine-HCI pH 2.8 or 4 M guanidine. These preparations, termed
the acid washes, were immediately adjusted to pH 7 .5 and extensively dialyzed against PBS.
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Polyacrylamide Gel Electrophoresis .
￿
Analytical disc electrophoresis was performed as described
by Ornstein (14) and Davis (15) using a 5% concentration of monomer in the lower gel . The protein
bands were stained with Coomassie blue (16) in 12% trichloroacetic acid. The gels were traced in a
Gilford 240spectrophotometer (Gilford Instrument Laboratories, Inc., Oberlin, Ohio) at 610mu . The
scanswere then carefully traced with a Keuffel andEsser 423M compensating planimeter (Keuffel&
Esser Co ., Morristown, N. J .) and the relative amounts of protein in the AFP, albumin, and
transferrin regions were calculated as a percent of the total area measured in arbitrary units . The
position of the proteins in the polyacrylamide gels were determined by placing the unstained gels on
agar contained in a petri dish with monospecific antisera in the lateral troughs . This technique has
been previously described (17) .
Preparative disc electrophoresis was carried out using a Shandon model SAE-2782 (Shandon
Scientific Co ., London) . Thebuffer system used was identical to that used in the qualitative gels (pH
9.3 Tris-HCl, 0.06 M) . A 10.0 cm 5% gel was used and the temperature maintained at 10°C with a
circulating water bath . No stacking gel was used, instead the sample was applied to the top of the
separating gel in stacking buffer (pH 6.9) made 30% in sucrose . Electrophoresis was carried out at
25-30mA (350 V) with apump rate of 25 ml/h and 2-ml fractions were collected over aperiod of 16 h.
Electrophoresis with sodium dodecyl sulfate in 10% polyacrylamide gel was performed according to
the method of Weber and Osborn (18) .
Isoelectric Focusing.
￿
Sucrose density gradient isoelectric focusing was performed as previously
described (12) . An Ampholine column LKB 8102 (LKB Instruments, Inc., Rockville, Md .) with 2%
carrier ampholytes of pH range 3-6 was used in most experiments . The isoelectrically separated
proteins were eluted, optical density measured at 280 mu, and the pH was measured at 25°C to
determine the isoelectric points of the separated protein components as defined by Ouchterlony gel
diffusion with monospecific antisera .
Spleen Cell Cultures
PRIMARY IN VITRO ANTIBODY SYNTHESIS . Primary synthesis to sheep erythrocytes (SRBC) was
measured using the method described by Marbrook (19) . 20-30 x 108CBAspleen cells were cultured
with 2 x 108SRBC in Medium 1066 (Grand Island Biochemical Co ., GrandIsland,N.Y .) containing
15% fetal calf serum and supplemented with glutamine (200 mM), streptomycin (10,000 7/ml), and
penicillin (10,000U/ml).Thecultures were incubated at 37°C for 5 days in an atmosphere of 10% CO,
and90% compressed air .Thelocalized hemolysis-in-gel technique was used with themodifications of
Wortis and Dresser (20) to detect and enumerate cellular synthesis of 7M antibody (direct
plaque-forming cells [PFC ]) . The antibody responses are expressed as mean yM PFC per culture t
SE (standard error of the mean) . Each preparation was cultured in triplicate . Preparations to be
tested for immunosuppressive activity were added in 0 .1 ml at the beginning of culture unless
otherwise stated .
SECONDARY IN VITRO ANTIBODY SYNTHESIS .
￿
Secondary synthesis toSRBC was measured by a micro
adaptation of the Mishell-Dutton system (21) . Spleen cells from mice primed with 5 x 108 SRBC 4
days previously were cultured for 5 days in flat-bottom Micro-Test tissue culture plates (Falcon
Plastics, Div . of BioQuest, Oxnard, Calif.) without rockingandwithout daily supplemental feeding .
Preliminary experiments showed that optimal conditions for cell density andantigen concentrations
were 3 .33 x 10 8 cells/ml and 10 x 10 8SRBC respectively . Cultures were setup in a total vol of 0.3 ml
in thefollowing order : (a) 0.1 ml of antigen, (b) 0.1 ml of media, and (c) 1 x 10 8 primed spleen cells in
0.1 ml . Themediaused wasHank'sMEM made up with supplements in the following proportions: 90
ml H,0, 10 ml Hank's MEM (10 x), 1 ml nonessential amino acids (100 x), 1 ml I,-glutamine (200
mM), 0.5 ml penicillin andstreptomycin (5,000 U/ml), 0.5 ml sodium pyruvate (20 x), 10 ml fetal calf
serum, 4 ml sodium bicarbonate (7 .5%), and 1 ml Hepes buffer (1 M) . Preparations to be tested for
immunosuppressive activity were added in 0.02 ml at the beginning of culture unless otherwise
stated . After the 5-day culture period in an atmosphere of 5% CO, and95% compressed air, the cells
were removed from the microplate wells by gentle aspiration with aPasteur pipette . Usually 12, and
sometimes 24, wellswere pooled, washed and resuspended in 1.0 ml of M199 (GIBCO), andcounted
in a hemocytometer just before the direct and indirect PFC assays . Class-specific rabbit antimouse
yA, 7G, 7G28, yG,,, and -yG, immunoglobulins were titrated to determinetheoptimal dilutions for
development of indirect PFC as previously described (11) . The number of indirect plaques was
calculated as the total plaques developed with facilitating antisera minus the plaques on identical272
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plates with added complement only (direct PFC) . The numbers of PFC of each of the six mouse
immunoglobulin classes are expressed as PFC/108 spleen cells.
Results
Effect of MAF on the yM PFC Response In Vitro.
￿
Cultures of CBA/J spleen
cells were stimulated with SRBC in the presence of various dilutions of MAF. 'YM
PFC responses were determined after 5 days of incubation and compared to
responses in control cultures (Table I) . There was profound suppression of the
PFC response when MAF was present in the cultures at a 1 :12 final dilution and
TABLE I
Dose-Response Effect of MAF on the In Vitro Primary Antibody
Response
* Final dilution of MAF in the culture.
the suppressive effect gradually diminished as the MAF was further diluted.
However, a significant degree of suppression was still evident at a 1/550 dilution
of MAF. Viability, as measured by trypan blue dye exclusion of the recovered
cells from each group of cultures containing the various dilutions of MAF did not
differ from control cultures . Thus it was evident that MAF contained a
substance(s) which was highly suppressive on primary in vitro antibody
synthesis . Additional studies showed that the suppressive effect of MAF was not
abolished by exhaustiN-o dialysis or by absorption with SRBC; and, furthermore,
it was clear from the viability studies that this activity was not due to a
nonspecific cytotoxic effect on the cultured mouse lymphocytes .
Immunochemical Analysis of the Protein Components of MAF.
￿
An analysis
of the protein content of MAF by immunoelectrophoresis and analytical
polyacrylamide gel electrophoresis (Fig. 1 and 2) revealed three major protein
components which were defined immunologically with monospecific antisera as
albumin, AFP, and transferrin. The relative amounts of each of these proteins in
MAF, as determined by polyacrylamide gel densitometry and planimetry, was
36%, 50%, and 14% respectively. Since the total protein concentration of pooled
MAF was approximately 2 mg/ml (see methods section), it was estimated that
the concentration of albumin in MAF was 0.72 mg/ml, AFP was 1 .0 mg/ml and
transferrin was 0 .28 mg/ml . Isoelectric focusing of MAF in the pH range of 3-6
revealed two major peaks with pI's of 4 .22 and 4.55 which were defined by
Preparation
Mean % viability of
recovered cells
1SE
Mean
yM PFC 1 SE
Media 62 1 4 318 t 74
MAF (1/12)* 55 1 3 13 t6
MAF (1/22) 58 1 1 44 1 17
MAF (1/110) 51 1 2 101 t 25
MAF (1/550) 55 t 2 188 t 12
MAF (1/1,100) 57 t 3 248 f 61ROBERT A . MURGITA AND THOMAS B. TOMASI, JR .
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FIG. 1 .
￿
Immunoelectrophoresis of (1) NMS, (2) pure AFP (indicated by the arrow) isolated
by preparative disc electrophoresis, and (3) MAF. Upper trough contained rabbit anti-WMS .
Lowertrough contained rabbit anti-MAF .
FIG. 2 .
￿
Polyacrylamide gel electrophoresis of (A) MAF, (B) semi-purified AFP preparation
from the fall-through of an anti-WMS affinity column, and (C) pure AFP isolated by
preparative disc electrophoresis . Thethree major proteincomponents of mouse amniotic fluid,
albumin (Alb), a-fetoprotein (AFP), and transferrin (Tr) are indicated .274
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Ouchterlony analysis and analytical disc gels as a-fetoprotein and albumin
respectively . Transferrin was detected in the fraction nearest the cathode with a
pI of 6.0 .
Separation of the Immunosuppresive Activity in MAF by Affinity Chroma-
tography . In an attempt to determine whether the immunosuppressive ac-
tivity was associated with one of the three major protein components of MAF, a
series of antibody-agarose affinity columns were used to remove separately each
of the three proteins . Selective removal of albumin, AFP, and transferrin was
accomplished by passing MAF over antialbumin, anti -a-fetoprotein, and anti-
transferrin columns . MAF was also passed over an anti-whole mouse serum
(WMS) column in order to obtain an AFP preparation which had not been
subjected to acid elution since this could have had a detrimental effect on the
potential biological activity of the protein . All fall-throughs (nonretained
protein) and acid washes (retained proteins) were dialyzed against PBS, pH 7.2,
concentrated, and adjusted to similar protein concentrations on the basis of
optical density at 280 mp. . The albumin and transferrin obtained from the acid
washes of antialbumin and antitransferrin columns were not used because of
insufficient recoveries . The results shown in Table 11 indicate that when 0.1 ml of
each of the preparations from the affinity columns were added to spleen cell
cultures with antigen, the suppressive activity resided in those preparations
containing AFP and not in those which were depleted of AFP . These results
strongly suggested that AFP was the immunosuppressive moiety in MAF .
However, although the AFP preparation obtained by affinity chromatography
appeared uncontaminated by Ouchterlony analysis and immunoelectrophoresis,
analytical gels consistently revealed several components (see Fig. 2) . Therefore,
the possibility could not be excluded that one of these contaminating proteins
also possessed immunosuppressive activity .
Suppression of the In Vitro Primary Antibody Response by PureAFP .
￿
A pure
preparation of AFP was obtained by first passing the MAF over an anti-WMS
affinity column and then subjecting the semipurified AFP preparation to
TABLE 11
Suppression of the In Vitro Primary Antibody Response by MAF
Protein Components Fractionated by Affinity Chromatography
Preparation
￿
yM PFC/culture f SE
Media
￿
687 t 167
AFP°
￿
156 t 47
MAF-AFP° ￿702 t 97
AFP, ￿246 t 53
MAF-AFPd
￿
692 163
MAF-Alb, ￿142 t 48
MAF-Trf
￿
115 f 62
Fall-through anti-WMS affinity column (a); acid wash anti-WMS affinity
column (b); acid wash anti-AFP affinity column (c); fall-through anti-
AFP affinity column (d) ; fall-through antialbumin affinity column (e) ;
fall-through antitransferrin affinity column (f) .ROBERT A. MURGITA AND THOMAS B. TOMASI, JR.
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preparative polyacrylamide gel electrophoresis. The criteria ofpurity was asingle
band on the analytical disc gel (Fig. 2). The mol wt, as determined by sodium
dodecyl sulfate acrylamide electrophoresis, was 77,500 unreduced and 72,400
when reduced with 1% (0.14 M) a-mercaptoethanol. A scan of the pure protein
using the Cary Model 14 recording spectrophotometer revealed no absorption
maxima in the 240-300 mg region. An extension coefficient was calculated on the
basis of dry weight to the E27 801 = 2.0, which suggests that AFP has a very low
aromatic amino acid content.
The pure AFP was tested for immunosuppressive activity by adding it to
spleen cell cultures at a final concentration of 200 Ag/ml. As shown in Table III
the preparation was highly suppressive compared with controls consisting of
cultures to which just media, NMS, purified serum albumin, ortransferrin were
added in similar concentrations . The dose-response effect ofthe pure AFP shown
in Table IV demonstrates a dilution effect which is strikingly similar to the
dose-response effect for MAF (see Table I), assuming that the AFP concentration
in undiluted MAF is 1 mg/ml.
Effect of Preincubation of Spleen Cells with MAF on the In Vitro Primary
Antibody Responses. The duration of exposure of spleen cells to MAF in
cultures without antigen necessary to achieve suppression of a subsequent
primary immune response was determined . 30 x 108 spleen cells in avol of1.1 ml
TABLE III
Suppression of the In Vitro Primary Antibody Response by
Purified Mouse a-Fetoprotein
* Final concentration in the culture.
TABLE IV
Dose-Response Effect of Purified Mouse a-Fetoprotein on the In
Vitro Primary Antibody Response
* Final concentration of AFP in the culture.
Preparation yM PFC/culture f SE
Media 423 t 12
AFP(200ug/ml)* 29 t 4
AFP(100 ug/ml) 60 t 3
AFP (10ug/ml) 78 f 11
AFP(I ug/ml) 154 t 17
AFP(0.1 ug/ml) 323 t 23
Preparation yM PFC/culture t SE
Media 766 t 151
AFP (200ug/ml)* 49 t 30
NMS (200 ug/ml) 635 f 85
Albumin (200 ug/ml) 491 t 60
Transferrin (200 ug/ml) 742 t 96276
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were preincubated with 0.1 ml MAF at various intervals, excess MAF was
removed by washing, and antigen was then added . The primary yM PFC
response was measured 5 days after addition of antigen . The percent viability of
recovered spleen cells was equivalent in cultures preincubated in MAF or just
media alone . Suppression was evident after 4 h of preincubation, but 8 h of
exposure was required for a suppressive effect comparable to when MAF was
present for the entire culture period (Table V) .
Effect of Time of Addition ofMAFon Primary Antibody Synthesis by Spleen
Cell Cultures . MAF was added at various intervals after initiation of spleen cell
cultures to determine whether the suppressive effect would occur only as an early
Preparation
TABLE V
Effect ofPreincubationofSpleen Cells with MAFon In Vitro Primary Antibody Synthesis
* 0.1 ml undilutedMAFwas added to 30 x 10 8 spleen cells in a total vol of 1 .2 ml .
yM PFC/culture t SE
event or at later stages of the immune response . As shown in Table VI, a sharp
delineation occurred between 24 and 48 h; suppression was pronounced when
added at 12 or 24 h after initiation, but no suppression occurred when MAF was
added 48 h after initiation of culture . This is further evidence that inhibition is
not the result of nonspecific cell death.
Dose-Response Effect of MAF on the In Vitro Secondary Antibody Re-
sponse. Experiments were done to determine whether MAF and pure AFP
could exert suppressive effects on the secondary antibody response and if so to
compare the relative strength of suppression by a given amount of protein on the
primary and secondary response . The PFC response in all six known classes of
mouse immunoglobulins (Ig) were measured to determine whether there was any
preferential or selective suppressive effects on the different Ig classes . The
dose-response effect ofMAF on thesecondary response shown in Table VII is very
4h in media 710 ±:314
4h inMAF 127 -±:39
8h in media 316 t 51
8hinMAF 1414
12 h in media 236 f 17
12hinMAF 13f7
24 h in media 209 t 8
24 h in MAF 18 t 11
Controls (no preincubation) 394 f 27
MAF present throughout culture period* 31 t 10
Cellssuspended inMAF andwashed immediately* 341 t 12
Cells preincubated :*
2h in media 291 t 28
2hinMAF 231 t 33ROBERT A. MURGITA AND THOMAS B. TOMASI, JR.
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TABLE VI
Effect of Time of Addition of MAF on Primary Antibody
Synthesis by Spleen Cell Cultures
* 0.1 ml of undiluted MAF was added to Marbrook cultures at times
shown . All cultures carried out for 5 days.
TABLE VII
Dose-Response Effect of MAF Secondary Antibody Response*
* CBAspleen cells from mice primed with 10' SRBC 4days previously were cultured at 1 x 108/0.3 ml
for 5 days with 10' SRBC.
$ Final dilution of MAF in culture.
similar to results obtained on the primary response (Table 1) . A partial
suppression was obtained with a 1:110 dilution of MAF and cultures treated with
a 1:550 dilution are approaching control values in some Ig classes. There is a
suggestion that yM PFC levels areless suppressed at thehigher dilutions of MAF
than are the other Ig classes.
Suppression of the In Vitro Secondary Antibody Response by MAF Protein
Components Fractionated by Affinity Chromatography. MAF was selectively
depleted of albumin, transferrin, and AFP by antibody-agarose affinity columns
as described in experiments on the primary antibody response (Table 11) . It was
shown that the inhibitory effect of MAF on the secondary response was abolished
by the selective removal of AFP, whereasfractions from the affinity columns that
are rich in AFP are strongly immunosuppressive (Table VIII). These experiments
again demonstrate that most or all of the immunosuppressive activity in MAF is
associated with the AFP component and not with the other proteins present in
the fluid.
Suppression of theIn Vitro SecondaryAntibody Response by Pure AFP.
￿
Pure
Preparation
-yM yA
PFC/108
-yG,
spleen cells
-yG,a yGze yG,
Control 83 116 433 125 150 416
MAF (1/12)$ 0 0 0 0 0 0
MAF (1/22) 16 0 0 0 0 0
MAF (1/110) 28 20 50 1 3 8
MAF (1/550) 90 100 140 60 110 160
Preparation yM PFC/culture t SE
Media 394 f 62
MAF added at zero time* 61 +61
MAFadded at 12 h* 39 t 10
MAFadded at 24 h* 97 t 23
MAFadded at 48 h* 385 t 95
MAFadded at 72 h* 587 t 18
MAFadded at 96 h* 497 t 230278
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AFP obtained by preparative disc electrophoresis (Fig . 2) was added to CBA
spleen cells primed with SRBC in a final concentration of 200 ug/ml . The results
shown in Table IX clearly demonstrate that AFP but not similar amounts of
NMS, albumin, or transferrin can completely suppress the secondary antibody
response . Shown in Table X is the dose-response effect of pure AFP on the
secondary antibody response . A clear distinction can be seen between the
effective doses needed for suppression of secondaryyM compared to the other Ig
classes . Secondary yM PFC were only partially suppressed at 100 ug/ml of AFP
whereas the other Ig classes are almost completely suppressed at this concentra-
tion . There was incomplete suppression of secondaryyM PFC at 10Ag/ml ofAFP
and no suppression with 1 Ag/ml. These concentrations gave a much higher
degree of suppression of primary yM PFC (see Table IV) . Therefore, secondary
yM PFC appear to be more resistant to suppression by AFP than are primaryyM
PFC . The secondary yA and yG-related PFC responses were more sensitive than
the primary aM PFC response to suppression by AFP.
TABLE VIII
Suppression of In Vitro Secondary Antibody Synthesis by MAF Protein Components
Fractionated by Affinity Chromatography
* CBA spleen cells from mice primed with 10' SRBC 4 days previously were cultured at 1 x 106
cells/0 .3 ml for 5 days with 10' SRBC .
Fall-through anti-WMS affinity column (a) ; Acid wash anti-WMS affinity column (b) ; acid wash
anti-AFP affinity column (c) ; fall-through anti-AFP affinity column (d) .
TABLE IX
Suppression of the In Vitro Secondary Antibody Response by Purified Mouse AFP
* CBA spleen cells from mice primed with 10' SRBC 4 days previously were cultured at 1 x 10 6
cells/0.3 ml for 5 days with 10' SRBC .
$ Final concentration in the culture .
Preparation
YM -yA
PFC/10 6
1YG .
spleen cells
-YGzs yGzb YGa
Media 394 326 608 214 326 946
AFP° 82 18 5 0 0 46
MAF-AFP° 364 293 546 192 293 850
AFP` 122 0 0 0 0 19
MAF-AFP° 490 480 823 568 470 882
Preparation
YM YA
PFC/106
YG,
spleen cells*
YGzs YGzn YG3
Media 120 225 340 245 260 400
AFP (200gg/ml)$ 2 0 8 0 2 0
NMS (200 gg/ml) 120 190 275 165 185 350
Albumin (200kg/ml) 80 175 200 165 190 330
Transferrin (200jcg/ml) 135 220 365 230 215 420ROBERT A. MURGITAANDTHOMAS B. TOMASI, JR .
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TABLE X
Dose-Response Effect of Purified Mouse AFP on In Vitro Secondary Antibody Response
* CBA spleen cells from mice primed with 10' SRBC 4 days previously were cultured at 1 x 10 6
cells/0.3 ml with 10' SRBC .
Discussion
The major purpose of this study was to determine whether AFP, both as it exists
in amniotic fluid and in the isolated form, has immunosuppressive activity .
Before discussing the results which directly focus on this problem, two observa-
tions in this study unrelated to immunosuppression by AFP bear mentioning . To
our knowledge this is the first study in which indirect plaques were quantitated
using an anti-yG3 -specific antiserum . It is somewhat surprising, in view of the
low serum concentrations of yG 3 (0 .1-0 .2 mg/ml in normal mouse serum [22]),
that this class is a major component of the antibody response to SRBC . In fact,
an average of the control plaques in the various classes obtained in all of our
experiments (see Tables VII, VIII, IX, and X) shows that -yG3 is the most
prevalent class respresenting approximately 30% of the total plaques developed
from in vivo primed spleen cells cultured 5 days with antigen in vitro. The
relative numbers of splenicyG 3 PFC were also unexpectedly high in the primary
in vivo response to SRBC (unpublished observation) . This observation suggests
the possibility that the synthetic rate of 7G 3 may be high and that the low serum
levels could result from rapid catabolism . Thesecond point concerns the very low
extinction coefficient for AFP (EZau mu = 2.0) . We have been unable to find an
extinction coefficient for AFP in the literature and in those studies where the
problem of protein quantitation is discussed, frequently serum albumin is used as
a standard (23) . This could potentially introduce serious errors into the quanti-
tation of AFP by any of the currently employed techniques .
In this investigation we have demonstrated that MAFcontains a nondialyzable
substance which is capable of exerting a noncytotoxic immunosuppressive effect
on primary and secondary antibody production in vitro . Polyacrylamide gel
analysis showed that dialyzed MAF is composed of approximately 14% transfer-
rin, 36% albumin, and 50% AFP. The selective removal of each of these proteins
from MAF by affinity chromatography showed that suppression of antibody
synthesis was retained when albumin or transferrin was removed but that there
was no suppressive effect in MAF which had been selectively depleted of AFP.
The conclusion implied from these experiments that AFP was the immunosup-
Preparation
yM yA
PFC/10 6
7G,
spleen cells*
yG 2a 1'Gze -yG,
Control 220 280 460 320 270 560
AFP (100 gg/ml) 87 0 22 0 0 54
AFP (10 gg/ml) 161 26 56 0 0 81
AFP (1 Jag/ml) 200 41 57 7 21 86
AFP (0 .1 fag/ml) 177 51 101 18 31 131
AFP (0.01 jug/ml) 227 118 181 132 116 367280
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pressive substance in MAF was verified by the subsequent demonstration that
pure AFP suppressed in vitro antibody synthesis whereas equivalent amounts of
normal mouse serum, transferrin, or albumin did not . Dose-response studies
showed that the suppressive effect of AFP in the isolated form was equivalent to
the suppressive effect of comparable amounts of AFP in MAF. These results
suggest that AFP was responsible for essentially all of the suppressive activity of
amniotic fluid . Suppression with purified AFP occurs at concentrations of 1
,ug/ml which is approximately 1,000-fold less than the levels present in mouse
serum at birth . Thus, if the in vitro results are applicable in vivo, the
concentration of AFP in the newborn is sufficient to provide significant
immunosuppression at birth and the disappearanceofAFPmay be a factor in the
gradual maturation of antibody responsiveness which occurs during the first few
weeks of life (24, 25) . Studies from this laboratory (10) involving the parenteral
administration of MAF from birth to young adulthood suggest that AFP is
capable of suppressing antibody synthesis in vivo .
The degree of suppression was dependent on the time at whichAFP was added
to the cultures ; MAF added to antigen-stimulated cultures up to 24 h after the
initiation of cultures was immunosuppressive whereas similar additions ofMAF
at 48, 72, and 96 h after initiation of cultures did not suppress . In fact, a slight
augmentation of thePFC response was observed whenMAF was added at 72 and
96 h after initiation of the cultures . These experiments also demonstrate the lack
of a nonspecific cytotoxic effect ofAFP or other constituents ofMAF on the cells
involved in in vitro antibody synthesis. The synthetic capacity of the antibody-
secreting (B) cell is apparently not affected by AFP since the addition to cultures
late in the antibody response did not suppress . However, this does not rule out
the possibility that AFPis inhibiting an earlier event in theB-cell contribution to
antibody synthesis . In fact, one or more of the earlyphases in antibody formation
such as antigen processing by macrophages, B-T cell interactions, or clonal
proliferation of antigen sensitive cells could be susceptible to the AFP-induced
suppression . Preincubation experiments (Table V) suggested that AFP must
interact with one or more of the cells involved in antibody production for
approximately 8 h for effective suppression . Briefer exposures resulted in little or
no suppression which suggests that the mechanism(s) involved in AFP-induced
suppression are more complex than simply blocking Ig receptors and prevention
of antigenic stimulation .
Although the exact mechanism(s) of immunosuppression induced by AFP
cannot be defined from the available data, an interesting speculation which
merits consideration is that a helper population of thymus-derived T cells for
antibody synthesis may be inhibited . There is some evidence to suggest that the
cellular events leading to the synthesis ofyA andyG antibodies to some antigens
are more dependent on thymus-derived cells than are the cellular systems which
lead to the synthesis ofyM antibodies (26-29) . Dose-response experiments using
pure AFP (Table X) demonstrated that secondary yA and yG PFC responses
were suppressed by greater than a 100-fold lower concentration ofAFP than were
secondary yM PFC. A 10-fold higher concentration of AFP was required to sup-
press the secondary yM compared with the primary yM PFC response (Table
IV). This difference in sensitivity to inhibition between direct and indirect PFCROBERT A. MURGITA AND THOMAS B. TOMASI, JR .
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responses is consistent with our recent findings (10) that animals injected with
MAF from birth through young adulthood had greater suppression of yA and -yG
responses to a primary injection ofSRBC compared with the -yM response which
was considerably less affected . Our observations therefore are consistent with
the concept that AFP is suppressing thymus-derivedT cells which are involved in
the mechanism of antibody synthesis . Data in a subsequent paper will show that
AFP also suppressed certain T-cell-dependent functions such as allogeneic and
mitogen-induced lymphocyte transformation .' In this regard, it is also interesting
to note that in one report (30) all patients studied with ataxia telangiectasia, a
disease involving an abnormal thymus and an immune deficiency, had raised
serum AFP concentrations . However, despite the suggestion that theT cell may
be involved, it has not been excluded that macrophages and/or B cells may
participate in the suppression rather than or in addition to T cells . It is also
conceivable that AFP stimulates a suppressor cell rather than inhibits a helper
cell . Obviously, further studies are neededon the cellular site(s) of action of AFP
using both thymus-dependent and independent antigens .
Substances present in normal (31, 32) and pregnant (33) sera have been shown
to nonspecifically inhibit the immune response . A factor in NMS has been
reported (34, 35) which is immunosuppressive for T-dependent but not T-
independent antigens . The level of this substance increases substantially
following immunization . The relationship of this factor to the a-regulatory
globulin described by Mowbray (36), discussed briefly below, as well as the
various suppressor substances reported to be present in pathological conditions
(37) is unknown. It has not been excluded that one or more of the factors
mentioned above are AFP. An a-globulin fraction from human, bovine, and rat
serum has immunosuppressive activity both in vivo and in vitro (38, 39) .
a-globulin-rich fractions from normal human plasma suppresses primary and
secondary antibody responses in vivo (40), and it has been suggested that the
active moiety is an immunoregulatory peptide which is noncovalently bound to
proteins with an electrophoretic mobility in the a-region (41) . Amniotic fluid
contains components which are derived from the maternal serum and, in fact, it
has been recently reported (42) that the adult-type plasma proteins found in
amniotic fluid are predominantly of maternal origin . Therefore, it must be
considered that at least part of the immunosuppressive activity of amniotic fluid
may be due to a maternal serum factor . However, as already discussed,
essentially all of the suppressive activity of MAF can be explained by its AFP
content . Another possibility in analogy with immunoregulatory a-globulin is that
the suppressive moiety ofAFP is a peptide bound to this glycoprotein . Although
it cannot be completely excluded, this possibility is made less likely by the fact
that one of the AFP preparations from an affinity column was subjected to low
pH (2 .8) and high salt (0.5 MNaCl) followed by extensive dialysis without loss of
suppressive activity . These conditions have been shown to favor elution of the
suppressive peptide from its carrier a-globulin (44) . Therefore, we believe that
AFP is probably not serving as a carrier protein for an immunosuppressive
peptide and that the suppressive activity is an intrinsic property of the AFP
molecule .
Anumber of polypeptide hormones have been reported to be immunosuppres-282
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sive (43). In our experiments there was no difference between native MAF and
MAF which had been exhaustively dialyzed and as mentioned above, affinity
chromatography at low pH and high salt followed by dialysis might be expected
to remove a noncovalently bound hormone. However, these findings do not
completely exclude the possibility of a suppressive hormone tightly bound to
AFP. AFP has recently been shown to have estrophilic activity (44), although it is
reported that estradiol does not directly influence the immune response (45) .
Although a considerable amount of information is now available concerning
the isolation, pathological distribution, and diagnostic significance of AFP, very
little is known about its biological function(s). No physiological explanation for
its presence during embryonic development has yet been determined . However,
it may not be fortuitous that a state of immunological hyporeactivity is often a
common element associated with conditions where AFP is prevalent. The
demonstration in this and a subsequent study' that AFP is a potent inhibitor of
the immune response leads us to hypothesize that this protein has as one of its
functions immunoregulatory activity. We speculate that AFP may have signifi-
cance as an immunoregulatory protein in three areas. Firstly, there is some
evidence that the maternal immune response is depressed at certain stages of
pregnancy (46, 47) and the elevated levels ofAFP in maternal sera could be one of
the responsible factors. Maternal immunosuppression in turn could contribute to
the delayed rejection of the developing histoincompatible fetus. It would be
interesting in this regard to know whether higher concentrations of AFP exist
locally in the uterine tissues surrounding the placenta than in the serum.
Secondly, numerous studies have demonstrated a reduced capacity of the fetus
and newborn to respond to antigenic stimuli (48). It should be emphasized that
this is not complete unresponsiveness and when the fetus does respond to
experimental inoculation of antigens or congenital infections there is usually a
high ratio of yM to yG production (49). This is consistent with the significantly
smaller suppressive effect ofAFP on yM production compared with other classes.
Two reasons come to mind why there might be a survival advantage to fetal
immunosuppression. Potentially antigenic substances ofbenefit to the fetus pass
from mother across the placenta andwere they to provoke an immune response in
the fetus they would be rapidly inactivated. For example, Warner et al. (50), in
discussing the acquisition by the fetus of foreign allotypes of immunoglobulin
present in the mother (either across the placenta or during nursing), point out
that the survival advantage of maternal antibodies would be seriously compro-
mised "unless the offspring were unable to respond to (were tolerant of) the
incompatible maternal globulins since an antibody response to maternal
immunoglobulins would lead very rapidly to their elimination." Another area
where fetal suppression may be important and perhaps a biological necessity is in
preventing reactivity against self-antigens . Cells with the capacity for self-recog-
nition have been shown to exist in both the adult (51, 52) and fetus (53). In fetal
and early newborn life, AFP could be important in suppressing autoimmunity
while later in development, after the disappearance of AFP, other factors
including the postulated blocking antibodies (54) become of prime importance.
Finally, AFP may have biological significance in later life when it appears as a
pathological marker ofembryo-specific differentiation in certain tissues undergo-ROBERT A . MURGITA AND THOMAS B. TOMASI, JR .
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ing rapid regeneration or malignant transformation . AFP could, for example, be
involved in the immunosuppression reported to be associated with liver disease
(55, 57) and certain tumors (57) . If so, then it may be an important factor in the
failure to eliminate viruses (such as those presumed to cause hepatitis or tumors)
and malignant cells .
Summary
Mouse amniotic fluid was shown to contain a noncytotoxic inhibitor of primary
yM and secondary yM, yA, andyG subclass splenic plaque forming cells in vitro
to SRBC . The suppressive effect was not abolished by exhaustive dialysis or by
absorption of mouse amniotic fluid (MAF) with SRBC.Polyacrylamide gel
analysis showed that dialyzed MAF was composed of three major protein
components, transferrin, albumin, and alpha -fetoprotein (AFP) . The selective
removal of each of these proteins from MAF by affinity chromatography
suggested that AFP was the immunosuppressive substance in MAR This
conclusion was verified by the demonstration that pure AFP suppressed in vitro
antibody synthesis in microgram quantities whereas equivalent amounts of
normal mouse serum, transferrin, or albumin did not . Dose-response studies
showed that the effect of AFP in the isolated form was equivalent to the
suppressive effect of comparable amounts of AFP in MAR yA and yG
plaque-forming cell (PFC) responses were suppressed by a significantly lower
concentration ofAFP than was theyM PFC response . The degree of suppression
was dependent on the time at whichAFP was added to the cultures ;MAF added
to antigen-stimulated cultures up to 24 h after initiation of cultures was
immunosuppressive whereas similar additions ofMAF at 48 h after initiation or
later did not suppress . The duration of exposure of spleen cells to MAF in
cultures without antigen necessary to achieve suppression of a subsequent
primary immune response was determined to be approximately 8 h .
The results suggest that AFP may have an immunoregulatory function . This
has potentially important implications in the maternal-fetal relationship, the
immune capabilities of the fetus and newborn, and in certain malignant and
nonmalignant diseases in which AFP is elevated .
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